411229-67-9

Usage

Uses

Used in Organic Chemical Synthesis:
4-(Cyclopropylmethoxy)benzeneboronic acid is used as a reagent for the formation of carbon-carbon and carbon-heteroatom bonds, playing a crucial role in various chemical reactions.
Used in the Suzuki-Miyaura Cross-Coupling Reaction:
In the field of organic chemistry, 4-(Cyclopropylmethoxy)benzeneboronic acid is utilized as a key component in the Suzuki-Miyaura cross-coupling reaction. This widely used method is essential for the synthesis of biaryl compounds, which are important structural motifs in pharmaceuticals, agrochemicals, and materials science.
Used in Pharmaceutical and Agrochemical Development:
Due to its unique reactivity and structural properties, 4-(Cyclopropylmethoxy)benzeneboronic acid has been studied for its potential use in the development of pharmaceuticals and agrochemicals. Its application in these fields can contribute to the discovery and development of new drugs and agrochemical products with improved efficacy and selectivity.

InChI:InChI=1/C10H13BO3/c12-11(13)9-3-5-10(6-4-9)14-7-8-1-2-8/h3-6,8,12-13H,1-2,7H2

Upstream product

• 411229-57-7 1-(cyclopropylmethoxy)-4-iodobenzene 
• 121-43-7 Trimethyl borate 

Downstream Products

• 693792-79-9 methyl N-{6-[4-(cyclopropylmethoxy)phenyl]pyrimidin-4-yl}-D-phenylalaninate 

Relevant academic research and scientific papers

PHENYL OR HETEROARYL AMINO ALKANE DERIVATIVES AS IP RECEPTOR ANTAGONIST

The present invention relates to a phenyl or heteroaryl amino alkane derivatives which are useful as an active ingredient of pharmaceutical preparations. The phenyl or heteroaryl amino alkanes of the present invention have IP receptor antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with IP receptor antagonistic activity. Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity. The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension; hemophilia and hemorrhage; and inflammation, since the diseases also is alleviated by treatment with an IP receptor antagonist.

Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents

Disclosed are substituted indoles, pharmaceutical compositions containing such indoles, and their use in treating or preventing PPAR-γ mediated diseases or conditions, such as osteopenia, osteoporosis, cancer, diabetes and atherosclerosis.